Status:
RECRUITING
PATH Program for for Severely Frail or Cognitively Impaired Patients Scheduled for Cancer Surgery.
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Frailty
Oncology Problem
Eligibility:
All Genders
75+ years
Phase:
NA
Brief Summary
This is a single center, non-blinded randomized control trial taking place at the Queen Elizabeth II hospital (QEII) in Nova Scotia. Patients are eligible if aged 75 and older scheduled for elective c...
Detailed Description
At Nova Scotia Health Authority (NSHA), geriatric medicine colleagues developed a preoperative palliative and therapeutic harmonization (PATH) clinic with the following objectives: 1. Assess medical ...
Eligibility Criteria
Inclusion
- Patients must have a clinically highly suspicious or pathologically confirmed diagnosis of bronchopulmonary, oropharyngeal (including head and neck surgery), orthopaedic, gynaecological, breast, genitourinary or gastrointestinal cancer surgery.
- Patients must be scheduled and consented for curative or palliative intent surgery.
- Patients must be aged 75 or older.
- Patients must be screened by the CFS to have:
- 4a. Mild or greater frailty (CFS equal or greater than 5) due to cognitive impairment.
- 4b. Moderate or greater frailty (CFS equal or greater than 6) due to medical/physical conditions.
- 5\. Informed consent for participation must be received.
Exclusion
- Patients cannot be a resident in a long-term care facility prior to the cancer diagnosis.
- Urgent/ emergent cases are excluded.
Key Trial Info
Start Date :
January 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06022666
Start Date
January 31 2024
End Date
March 1 2026
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QEII, Victoria General Hospital
Halifax, Nova Scotia, Canada, B3H 2Y9